O	O	0	17	Immunosuppressant	Immunosuppressant	B-NP	NN	O	2	NMOD	O
O	O	18	23	PG490	PG490	I-NP	NN	O	6	SUB	O
O	O	24	25	(	(	O	(	O	5	DEP	O
O	O	25	35	triptolide	triptolide	B-NP	NN	O	5	DEP	O
O	O	35	36	)	)	O	)	O	2	NMOD	O
O	O	37	45	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	46	47	T	T	B-NP	NN	O	13	NMOD	O
O	O	47	48	-	-	I-NP	HYPH	O	13	NMOD	O
O	O	48	52	cell	cell	I-NP	NN	O	13	NMOD	O
T1	B-Protein	53	64	interleukin	interleukin	I-NP	NN	B-protein	13	NMOD	B-protein
T1	I-Protein	64	65	-	-	O	HYPH	I-protein	13	NMOD	I-protein
T1	I-Protein	65	66	2	2	B-NP	CD	I-protein	13	NMOD	I-protein
O	O	67	77	expression	expression	I-NP	NN	O	6	OBJ	O
O	O	78	80	at	at	B-PP	IN	O	6	VMOD	O
O	O	81	84	the	the	B-NP	DT	O	16	NMOD	O
O	O	85	90	level	level	I-NP	NN	O	14	PMOD	O
O	O	91	93	of	of	B-PP	IN	O	16	NMOD	O
O	O	94	100	purine	purine	B-NP	NN	B-DNA	34	NMOD	B-DNA
O	O	100	101	-	-	I-NP	HYPH	I-DNA	34	NMOD	I-DNA
O	O	101	104	box	box	I-NP	NN	I-DNA	34	NMOD	I-DNA
O	O	104	105	/	/	O	SYM	O	34	P	O
O	O	105	112	nuclear	nuclear	B-NP	JJ	O	23	NMOD	O
O	O	113	119	factor	factor	I-NP	NN	O	34	NMOD	O
O	O	120	122	of	of	B-PP	IN	O	23	NMOD	O
O	O	123	132	activated	activate	B-NP	VBN	B-cell_type	28	NMOD	B-cell_type
O	O	133	134	T	T	I-NP	NN	I-cell_type	28	NMOD	I-cell_type
O	O	134	135	-	-	I-NP	HYPH	I-cell_type	28	NMOD	I-cell_type
O	O	135	140	cells	cell	I-NP	NNS	I-cell_type	24	PMOD	I-cell_type
O	O	141	144	and	and	O	CC	O	34	NMOD	O
T9	B-Entity	145	147	NF	NF	B-NP	NN	B-protein	32	NMOD	B-protein
T9	I-Entity	147	148	-	-	B-NP	HYPH	I-protein	32	P	I-protein
T9	I-Entity	148	154	kappaB	kappaB	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	155	170	transcriptional	transcriptional	I-NP	JJ	O	34	NMOD	O
O	O	171	181	activation	activation	I-NP	NN	O	17	PMOD	O
O	O	181	182	.	.	O	.	O	6	P	O

O	O	184	189	PG490	PG490	B-NP	NN	O	5	SUB	O
O	O	190	191	(	(	O	(	O	4	DEP	O
O	O	191	201	triptolide	triptolide	B-NP	NN	O	4	DEP	O
O	O	201	202	)	)	O	)	O	1	NMOD	O
O	O	203	205	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	206	207	a	a	B-NP	DT	O	8	NMOD	O
O	O	208	217	diterpene	diterpene	I-NP	NN	O	8	NMOD	O
O	O	218	228	triepoxide	triepoxide	I-NP	NN	O	5	PRD	O
O	O	229	233	with	with	B-PP	IN	O	8	NMOD	O
O	O	234	240	potent	potent	B-NP	JJ	O	11	NMOD	O
O	O	241	258	immunosuppressive	immunosuppressive	I-NP	JJ	O	14	NMOD	O
O	O	259	262	and	and	I-NP	CC	O	14	NMOD	O
O	O	263	279	antiinflammatory	antiinflammatory	I-NP	JJ	O	14	NMOD	O
O	O	280	290	properties	property	I-NP	NNS	O	9	PMOD	O
O	O	290	291	.	.	O	.	O	5	P	O

O	O	292	297	PG490	PG490	B-NP	NN	O	2	SUB	O
O	O	298	306	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
T2	B-Protein	307	318	interleukin	interleukin	B-NP	NN	B-protein	5	NMOD	B-protein
T2	I-Protein	318	319	(	(	O	(	I-protein	5	NMOD	I-protein
T2	I-Protein	319	321	IL	IL	B-NP	NN	I-protein	9	NMOD	I-protein
T2	I-Protein	321	322	)	)	O	)	I-protein	5	NMOD	I-protein
T2	I-Protein	322	323	-	-	O	HYPH	I-protein	5	NMOD	I-protein
T2	I-Protein	323	324	2	2	B-NP	CD	I-protein	5	NMOD	I-protein
O	O	325	335	expression	expression	I-NP	NN	O	2	OBJ	O
O	O	336	338	by	by	B-PP	IN	O	9	NMOD	O
O	O	339	345	normal	normal	B-NP	JJ	B-cell_type	15	NMOD	B-cell_type
O	O	346	351	human	human	I-NP	JJ	I-cell_type	15	NMOD	I-cell_type
O	O	352	362	peripheral	peripheral	I-NP	JJ	I-cell_type	15	NMOD	I-cell_type
O	O	363	368	blood	blood	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	369	380	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	381	391	stimulated	stimulate	B-VP	VBN	O	15	NMOD	O
O	O	392	396	with	with	B-PP	IN	O	16	VMOD	O
O	O	397	404	phorbol	phorbol	B-NP	NN	O	17	PMOD	O
O	O	405	407	12	12	I-NP	CD	O	18	NMOD	O
O	O	407	408	-	-	O	HYPH	O	18	NMOD	O
O	O	408	417	myristate	myristate	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	418	420	13	13	I-NP	CD	I-protein	21	NMOD	I-protein
O	O	420	421	-	-	O	HYPH	O	21	P	O
O	O	421	428	acetate	acetate	B-NP	NN	O	29	NMOD	O
O	O	429	430	(	(	O	(	O	27	DEP	O
O	O	430	433	PMA	PMA	B-NP	NN	O	27	DEP	O
O	O	433	434	)	)	O	)	O	24	NMOD	O
O	O	435	438	and	and	O	CC	O	29	NMOD	O
O	O	439	447	antibody	antibody	B-NP	NN	O	20	PMOD	O
O	O	448	450	to	to	B-PP	TO	O	29	NMOD	O
T10	B-Entity	451	454	CD3	CD3	B-NP	NN	B-protein	30	PMOD	B-protein
O	O	455	456	(	(	O	(	O	39	DEP	O
O	O	456	460	IC50	IC50	B-NP	NN	O	39	DEP	O
O	O	461	463	of	of	B-PP	IN	O	33	NMOD	O
O	O	464	466	10	10	B-NP	CD	O	38	NMOD	O
O	O	467	469	ng	ng	I-NP	NN	O	38	NMOD	O
O	O	469	470	/	/	B-NP	SYM	O	38	NMOD	O
O	O	470	472	ml	ml	I-NP	NN	O	34	PMOD	O
O	O	472	473	)	)	O	)	O	29	NMOD	O
O	O	473	474	,	,	O	,	O	29	P	O
O	O	475	478	and	and	O	CC	O	29	NMOD	O
O	O	479	483	with	with	B-PP	IN	O	41	PMOD	O
O	O	484	487	PMA	PMA	B-NP	NN	O	45	NMOD	O
O	O	488	491	and	and	O	CC	O	45	NMOD	O
O	O	492	501	ionomycin	ionomycin	B-NP	NN	O	42	PMOD	O
O	O	502	503	(	(	O	(	O	55	DEP	O
O	O	503	507	Iono	Iono	B-NP	NN	O	49	NMOD	O
O	O	507	508	,	,	O	,	O	49	P	O
O	O	509	513	IC50	IC50	B-NP	NN	O	55	DEP	O
O	O	514	516	of	of	B-PP	IN	O	49	NMOD	O
O	O	517	519	40	40	B-NP	CD	O	54	NMOD	O
O	O	520	522	ng	ng	I-NP	NN	O	54	NMOD	O
O	O	522	523	/	/	B-NP	SYM	O	54	P	O
O	O	523	525	ml	ml	I-NP	NN	O	50	PMOD	O
O	O	525	526	)	)	O	)	O	45	NMOD	O
O	O	526	527	.	.	O	.	O	2	P	O

O	O	528	530	In	In	B-PP	IN	O	8	VMOD	O
O	O	531	537	Jurkat	Jurkat	B-NP	NN	B-cell_line	5	NMOD	B-cell_line
O	O	538	539	T	T	I-NP	NN	I-cell_line	5	NMOD	I-cell_line
O	O	539	540	-	-	B-NP	HYPH	I-cell_line	5	NMOD	I-cell_line
O	O	540	545	cells	cell	I-NP	NNS	I-cell_line	1	PMOD	I-cell_line
O	O	545	546	,	,	O	,	O	8	P	O
O	O	547	552	PG490	PG490	B-NP	NN	O	8	SUB	O
O	O	553	561	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	562	565	PMA	PMA	B-NP	NN	O	17	NMOD	O
O	O	565	566	/	/	B-NP	SYM	O	17	NMOD	O
O	O	566	570	Iono	Iono	I-NP	NN	O	17	NMOD	O
O	O	570	571	-	-	O	HYPH	O	11	P	O
O	O	571	581	stimulated	stimulate	B-NP	VBN	O	17	NMOD	O
T3	B-Protein	582	584	IL	IL	I-NP	NN	B-protein	17	NMOD	B-protein
T3	I-Protein	584	585	-	-	I-NP	HYPH	I-protein	17	NMOD	I-protein
T3	I-Protein	585	586	2	2	B-NP	CD	I-protein	17	NMOD	I-protein
O	O	587	600	transcription	transcription	I-NP	NN	O	8	OBJ	O
O	O	600	601	.	.	O	.	O	8	P	O

O	O	602	607	PG490	PG490	B-NP	NN	O	2	SUB	O
O	O	608	616	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	617	620	the	the	B-NP	DT	O	4	NMOD	O
O	O	621	630	induction	induction	I-NP	NN	O	2	OBJ	O
O	O	631	633	of	of	B-PP	IN	O	4	NMOD	O
O	O	634	637	DNA	DNA	B-NP	NN	O	8	NMOD	O
O	O	638	645	binding	binding	I-NP	NN	O	8	NMOD	O
O	O	646	654	activity	activity	I-NP	NN	O	5	PMOD	O
O	O	655	657	at	at	B-PP	IN	O	4	NMOD	O
O	O	658	661	the	the	B-NP	DT	O	29	NMOD	O
T11	B-Entity	662	668	purine	purine	I-NP	NN	B-DNA	29	NMOD	B-DNA
T11	I-Entity	668	669	-	-	B-NP	HYPH	I-DNA	29	P	I-DNA
T11	I-Entity	669	672	box	box	I-NP	NN	I-DNA	29	NMOD	I-DNA
T11	I-Entity	672	673	/	/	I-NP	SYM	O	29	P	O
T11	I-Entity	673	680	antigen	antigen	I-NP	NN	O	18	NMOD	O
T11	I-Entity	681	689	receptor	receptor	I-NP	NN	O	18	NMOD	O
T11	I-Entity	690	698	response	response	I-NP	NN	O	18	NMOD	O
T11	I-Entity	699	706	element	element	I-NP	NN	O	29	NMOD	O
T11	I-Entity	707	708	(	(	O	(	O	21	DEP	O
T11	I-Entity	708	712	ARRE	ARRE	B-NP	NN	B-DNA	21	DEP	B-DNA
T11	I-Entity	712	713	)	)	O	)	O	18	NMOD	O
T11	I-Entity	713	714	/	/	O	SYM	O	29	P	O
T11	I-Entity	714	721	nuclear	nuclear	B-NP	JJ	B-protein	24	NMOD	B-protein
T11	I-Entity	722	728	factor	factor	I-NP	NN	I-protein	29	NMOD	I-protein
T11	I-Entity	729	731	of	of	B-PP	IN	I-protein	29	NMOD	I-protein
T11	I-Entity	732	741	activated	activate	B-NP	VBN	I-protein	29	NMOD	I-protein
T11	I-Entity	742	743	T	T	I-NP	NN	I-protein	29	NMOD	I-protein
T11	I-Entity	743	744	-	-	O	HYPH	I-protein	29	NMOD	I-protein
T11	I-Entity	744	749	cells	cell	B-NP	NNS	I-protein	36	NMOD	I-protein
T11	I-Entity	750	751	(	(	O	(	O	34	DEP	O
T11	I-Entity	751	753	NF	NF	B-NP	NN	B-protein	33	NMOD	B-protein
T11	I-Entity	753	754	-	-	I-NP	HYPH	I-protein	33	P	I-protein
T11	I-Entity	754	756	AT	AT	I-NP	NN	I-protein	34	DEP	I-protein
T11	I-Entity	756	757	)	)	I-NP	)	O	29	NMOD	O
T11	I-Entity	758	764	target	target	I-NP	NN	O	36	NMOD	O
T11	I-Entity	765	773	sequence	sequence	I-NP	NN	O	9	PMOD	O
O	O	774	777	but	but	B-PP	CC	O	9	PMOD	O
O	O	778	781	not	not	B-PP	RB	O	9	PMOD	O
O	O	782	784	at	at	I-PP	IN	O	9	PMOD	O
O	O	785	788	the	the	B-NP	DT	O	44	NMOD	O
T12,T13	B-Entity,B-Entity	789	791	NF	NF	I-NP	NN	B-DNA	44	NMOD	B-DNA
T12,T13	I-Entity,I-Entity	791	792	-	-	B-NP	HYPH	I-DNA	44	NMOD	I-DNA
T12,T13	I-Entity,I-Entity	792	798	kappaB	kappaB	I-NP	NN	I-DNA	44	NMOD	I-DNA
T12	I-Entity	799	803	site	site	I-NP	NN	I-DNA	39	PMOD	I-DNA
O	O	803	804	.	.	O	.	O	2	P	O

O	O	805	810	PG490	PG490	B-NP	NN	O	2	SUB	O
O	O	811	814	can	can	B-VP	MD	O	0	ROOT	O
O	O	815	825	completely	completely	I-VP	RB	O	2	VMOD	O
O	O	826	833	inhibit	inhibit	I-VP	VB	O	2	VC	O
O	O	834	849	transcriptional	transcriptional	B-NP	JJ	O	6	NMOD	O
O	O	850	860	activation	activation	I-NP	NN	O	4	OBJ	O
O	O	861	863	at	at	B-PP	IN	O	4	VMOD	O
O	O	864	867	the	the	B-NP	DT	O	24	NMOD	O
O	O	868	874	purine	purine	I-NP	NN	B-DNA	24	NMOD	B-DNA
O	O	874	875	-	-	B-NP	HYPH	I-DNA	24	NMOD	I-DNA
O	O	875	878	box	box	I-NP	NN	I-DNA	24	NMOD	I-DNA
O	O	878	879	/	/	I-NP	SYM	O	24	P	O
O	O	879	883	ARRE	ARRE	I-NP	NN	B-DNA	24	NMOD	B-DNA
O	O	883	884	/	/	B-NP	SYM	O	24	NMOD	O
O	O	884	886	NF	NF	I-NP	NN	B-protein	17	NMOD	B-protein
O	O	886	887	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
O	O	887	889	AT	AT	I-NP	NN	I-protein	24	NMOD	I-protein
O	O	890	893	and	and	I-NP	CC	O	24	NMOD	O
O	O	894	896	NF	NF	I-NP	NN	O	24	NMOD	O
O	O	896	897	-	-	B-NP	HYPH	O	24	NMOD	O
O	O	897	903	kappaB	kappaB	I-NP	NN	B-DNA	24	NMOD	B-DNA
T14	B-Entity	904	910	target	target	I-NP	NN	I-DNA	24	NMOD	I-DNA
T14	I-Entity	911	914	DNA	DNA	I-NP	NN	I-DNA	24	NMOD	I-DNA
T14	I-Entity	915	924	sequences	sequence	I-NP	NNS	I-DNA	7	PMOD	I-DNA
O	O	925	934	triggered	trigger	B-VP	VBN	O	24	NMOD	O
O	O	935	937	by	by	B-PP	IN	O	25	VMOD	O
O	O	938	941	all	all	B-NP	DT	O	28	NMOD	O
O	O	942	949	stimuli	stimulus	I-NP	NNS	O	26	PMOD	O
O	O	950	958	examined	examine	B-VP	VBN	O	28	NMOD	O
O	O	959	960	(	(	O	(	O	42	DEP	O
O	O	960	963	PMA	PMA	B-NP	NN	O	41	NMOD	O
O	O	963	964	,	,	O	,	O	41	P	O
O	O	965	968	PMA	PMA	B-NP	NN	O	41	NMOD	O
O	O	968	969	/	/	B-VP	SYM	O	41	P	O
O	O	969	973	Iono	Iono	B-NP	NN	O	41	NMOD	O
O	O	973	974	,	,	O	,	O	41	P	O
T4	B-Protein	975	980	tumor	tumor	B-NP	NN	B-protein	41	NMOD	B-protein
T4	I-Protein	981	989	necrosis	necrosis	I-NP	NN	I-protein	41	NMOD	I-protein
T4	I-Protein	990	996	factor	factor	I-NP	NN	I-protein	41	NMOD	I-protein
T4	I-Protein	996	997	-	-	O	HYPH	I-protein	41	P	I-protein
T4	I-Protein	997	1002	alpha	alpha	B-NP	SYM	I-protein	42	DEP	I-protein
O	O	1002	1003	)	)	O	)	O	28	NMOD	O
O	O	1003	1004	.	.	O	.	O	2	P	O

O	O	1005	1010	PG490	PG490	B-NP	NN	O	3	SUB	O
O	O	1011	1015	also	also	B-ADVP	RB	O	3	VMOD	O
O	O	1016	1024	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	1025	1028	PMA	PMA	B-NP	NN	O	3	OBJ	O
O	O	1028	1029	-	-	O	HYPH	O	4	NMOD	O
O	O	1029	1039	stimulated	stimulate	B-NP	VBN	O	7	NMOD	O
O	O	1040	1050	activation	activation	I-NP	NN	O	5	OBJ	O
O	O	1051	1053	of	of	B-PP	IN	O	7	NMOD	O
O	O	1054	1055	a	a	B-NP	DT	O	12	NMOD	O
O	O	1056	1064	chimeric	chimeric	I-NP	JJ	B-protein	12	NMOD	B-protein
O	O	1065	1078	transcription	transcription	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	1079	1085	factor	factor	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	1086	1088	in	in	B-PP	IN	O	7	NMOD	O
O	O	1089	1094	which	which	B-NP	WDT	O	13	PMOD	O
O	O	1095	1098	the	the	B-NP	DT	O	21	NMOD	O
T15	B-Entity	1099	1100	C	C	I-NP	NN	B-protein	21	NMOD	B-protein
T15	I-Entity	1100	1101	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T15	I-Entity	1101	1109	terminal	terminal	I-NP	JJ	I-protein	21	NMOD	I-protein
T15	I-Entity	1110	1113	TA1	TA1	I-NP	NN	I-protein	21	NMOD	I-protein
T15	I-Entity	1114	1129	transactivation	transactivation	I-NP	NN	I-protein	21	NMOD	I-protein
T15	I-Entity	1130	1136	domain	domain	I-NP	NN	I-protein	27	SUB	I-protein
O	O	1137	1139	of	of	B-PP	IN	O	21	NMOD	O
O	O	1140	1142	NF	NF	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	1142	1143	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
O	O	1143	1149	kappaB	kappaB	I-NP	NN	I-protein	26	NMOD	I-protein
T5	B-Protein	1150	1153	p65	p65	I-NP	NN	I-protein	22	PMOD	I-protein
O	O	1154	1156	is	be	B-VP	VBZ	O	13	SBAR	O
O	O	1157	1162	fused	fuse	I-VP	VBN	O	27	VC	O
O	O	1163	1165	to	to	B-PP	TO	O	28	VMOD	O
O	O	1166	1169	the	the	B-NP	DT	O	33	NMOD	O
T16	B-Entity	1170	1173	DNA	DNA	I-NP	NN	B-protein	33	NMOD	B-protein
T16	I-Entity	1174	1181	binding	binding	I-NP	NN	I-protein	33	NMOD	I-protein
T16	I-Entity	1182	1188	domain	domain	I-NP	NN	I-protein	29	PMOD	I-protein
O	O	1189	1191	of	of	B-PP	IN	O	33	NMOD	O
T6	B-Protein	1192	1196	GAL4	GAL4	B-NP	NN	B-protein	34	PMOD	B-protein
O	O	1196	1197	.	.	O	.	O	3	P	O

O	O	1198	1200	In	In	B-PP	IN	O	26	VMOD	O
O	O	1201	1206	16HBE	16HBE	B-NP	NN	B-cell_line	6	NMOD	B-cell_line
O	O	1207	1212	human	human	B-NP	JJ	I-cell_line	6	NMOD	I-cell_line
O	O	1213	1222	bronchial	bronchial	I-NP	JJ	I-cell_line	6	NMOD	I-cell_line
O	O	1223	1233	epithelial	epithelial	I-NP	JJ	I-cell_line	6	NMOD	I-cell_line
O	O	1234	1239	cells	cell	I-NP	NNS	I-cell_line	1	PMOD	I-cell_line
O	O	1239	1240	,	,	O	,	O	26	P	O
T7	B-Protein	1241	1243	IL	IL	B-NP	NN	B-protein	11	NMOD	B-protein
T7	I-Protein	1243	1244	-	-	O	HYPH	I-protein	11	NMOD	I-protein
T7	I-Protein	1244	1245	8	8	B-NP	CD	I-protein	11	NMOD	I-protein
O	O	1246	1256	expression	expression	I-NP	NN	O	12	SUB	O
O	O	1257	1259	is	be	B-VP	VBZ	O	26	VMOD	O
O	O	1260	1269	regulated	regulate	I-VP	VBN	O	12	VC	O
O	O	1270	1283	predominantly	predominantly	B-ADVP	RB	O	13	VMOD	O
O	O	1284	1286	by	by	B-PP	IN	O	13	VMOD	O
T17	B-Entity	1287	1289	NF	NF	B-NP	NN	B-protein	18	NMOD	B-protein
T17	I-Entity	1289	1290	-	-	I-NP	HYPH	I-protein	18	NMOD	I-protein
T17	I-Entity	1290	1296	kappaB	kappaB	I-NP	NN	I-protein	15	PMOD	I-protein
O	O	1296	1297	,	,	O	,	O	26	P	O
O	O	1298	1301	and	and	O	CC	O	26	VMOD	O
O	O	1302	1307	PG490	PG490	B-NP	NN	O	25	NMOD	O
O	O	1308	1311	but	but	B-NP	CC	O	25	NMOD	O
O	O	1312	1315	not	not	I-NP	RB	O	22	DEP	O
O	O	1316	1327	cyclosporin	cyclosporin	B-NP	NN	O	25	NMOD	O
O	O	1328	1329	A	A	I-NP	NN	O	26	SUB	O
O	O	1330	1333	can	can	B-VP	MD	O	0	ROOT	O
O	O	1334	1344	completely	completely	I-VP	RB	O	26	VMOD	O
O	O	1345	1352	inhibit	inhibit	I-VP	VB	O	26	VC	O
O	O	1353	1363	expression	expression	B-NP	NN	O	28	OBJ	O
O	O	1364	1366	of	of	B-PP	IN	O	29	NMOD	O
T8	B-Protein	1367	1369	IL	IL	B-NP	NN	B-protein	32	NMOD	B-protein
T8	I-Protein	1369	1370	-	-	B-NP	HYPH	I-protein	30	PMOD	I-protein
T8	I-Protein	1370	1371	8	8	I-NP	CD	I-protein	32	NMOD	I-protein
O	O	1371	1372	.	.	O	.	O	26	P	O

O	O	1373	1376	The	The	B-NP	DT	O	2	NMOD	O
O	O	1377	1386	mechanism	mechanism	I-NP	NN	O	10	SUB	O
O	O	1387	1389	of	of	B-PP	IN	O	2	NMOD	O
O	O	1390	1395	PG490	PG490	B-NP	NN	O	5	NMOD	O
O	O	1396	1406	inhibition	inhibition	I-NP	NN	O	3	PMOD	O
O	O	1407	1409	of	of	B-PP	IN	O	5	NMOD	O
T18	B-Entity	1410	1418	cytokine	cytokine	B-NP	NN	B-DNA	9	NMOD	B-DNA
T18	I-Entity	1419	1423	gene	gene	I-NP	NN	I-DNA	9	NMOD	I-DNA
O	O	1424	1434	expression	expression	I-NP	NN	O	6	PMOD	O
O	O	1435	1442	differs	differ	B-VP	VBZ	O	0	ROOT	O
O	O	1443	1447	from	from	B-PP	IN	O	10	VMOD	O
O	O	1448	1459	cyclosporin	cyclosporin	B-NP	NN	O	13	NMOD	O
O	O	1460	1461	A	A	I-NP	NN	O	11	PMOD	O
O	O	1462	1465	and	and	O	CC	O	10	VMOD	O
O	O	1466	1474	involves	involve	B-VP	VBZ	O	10	VMOD	O
O	O	1475	1482	nuclear	nuclear	B-NP	JJ	O	17	NMOD	O
O	O	1483	1493	inhibition	inhibition	I-NP	NN	O	30	NMOD	O
O	O	1494	1496	of	of	B-PP	IN	O	17	NMOD	O
O	O	1497	1512	transcriptional	transcriptional	B-NP	JJ	O	20	NMOD	O
O	O	1513	1523	activation	activation	I-NP	NN	O	18	PMOD	O
O	O	1524	1526	of	of	B-PP	IN	O	20	NMOD	O
T19	B-Entity	1527	1529	NF	NF	B-NP	NN	B-protein	24	NMOD	B-protein
T19	I-Entity	1529	1530	-	-	B-NP	HYPH	I-protein	24	NMOD	I-protein
T19	I-Entity	1530	1536	kappaB	kappaB	I-NP	NN	I-protein	21	PMOD	I-protein
O	O	1537	1540	and	and	O	CC	O	30	NMOD	O
O	O	1541	1544	the	the	B-NP	DT	O	30	NMOD	O
T20	B-Entity	1545	1551	purine	purine	I-NP	NN	B-protein	30	NMOD	B-protein
T20	I-Entity	1551	1552	-	-	I-NP	HYPH	I-protein	30	P	I-protein
T20	I-Entity	1552	1555	box	box	I-NP	NN	I-protein	30	NMOD	I-protein
T20	I-Entity	1556	1565	regulator	regulator	I-NP	NN	I-protein	15	OBJ	I-protein
O	O	1566	1575	operating	operate	B-VP	VBG	O	30	NMOD	O
O	O	1576	1578	at	at	B-PP	IN	O	30	NMOD	O
O	O	1579	1582	the	the	B-NP	DT	O	39	NMOD	O
T21	B-Entity	1583	1587	ARRE	ARRE	I-NP	NN	B-DNA	39	NMOD	B-DNA
T21	I-Entity	1587	1588	/	/	B-NP	SYM	O	39	P	O
T21	I-Entity	1588	1590	NF	NF	I-NP	NN	B-protein	39	NMOD	B-protein
T21	I-Entity	1590	1591	-	-	B-NP	HYPH	O	39	NMOD	O
T21	I-Entity	1591	1593	AT	AT	I-NP	NN	B-DNA	39	NMOD	B-DNA
T21	I-Entity	1594	1598	site	site	I-NP	NN	I-DNA	32	PMOD	I-DNA
O	O	1599	1601	at	at	B-PP	IN	O	39	NMOD	O
O	O	1602	1603	a	a	B-NP	DT	O	42	NMOD	O
O	O	1604	1608	step	step	I-NP	NN	O	40	PMOD	O
O	O	1609	1614	after	after	B-PP	IN	O	42	NMOD	O
O	O	1615	1623	specific	specific	B-NP	JJ	O	46	NMOD	O
O	O	1624	1627	DNA	DNA	I-NP	NN	O	46	NMOD	O
O	O	1628	1635	binding	binding	I-NP	NN	O	43	PMOD	O
O	O	1635	1636	.	.	O	.	O	10	P	O
